The research team of Prof. Yang Xu has made progress in the study of the impact of GLP-1 receptor agonists heart failure hospitalization risk in type 2 diabetes patients
Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University Health Science Center
Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University Health Science Center
Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University Health Science Center. The research team of Prof. Yang Xu has made progress in the study of the impact of GLP-1 receptor agonists heart failure hospitalization risk in type 2 diabetes patients[J]. Journal of Chinese Pharmaceutical Sciences, 2026, 35(7): 690-691.
>
>